FY 25 roche diabetes care BPA - medical supply
Active Awarded Last action
- Contract number
- 75H71025F80116
- Awardee
-
Roche Diabetes Care Inc. UEI F6JDDN8L9JM4
- Awarding agency
-
Indian Health Service
Department of Health and Human Services
- Obligated
- $244,000
Award facts
- Contract value 44% obligated
-
- $244,000.00 Current, with exercised options
- $550,000.00 Potential, with all options
- Completion date 32% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Indianapolis, IN 46250, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $40,000 | |
| Exercise an Option | $102,000 | |
| Original award | $102,000 |
About this award
The Indian Health Service awarded a $550K delivery order (Modification 2) to Roche Diabetes Care Inc., a diabetes care supplies manufacturer headquartered in Indianapolis, Indiana, to provide medical supplies for the Gallup Indian Medical Center. This delivery order represents additional funding under an existing blanket purchase agreement and operates under Roche's GSA Federal Supply Schedule contract for In-Vitro Diagnostics, Reagents, and Test Kits (FSS-65-VII). The award carries a firm fixed-price structure with no set-aside designation and an ultimate completion date of March 31, 2030. Performance will take place at Roche's Castleton, Indiana facility.
This delivery order supports the Indian Health Service's diabetes management and care programs serving American Indian and Alaska Native populations. Roche Diabetes Care Inc. is an established federal supplier with a demonstrated history of providing blood glucose monitors, test strips, lancets, control solutions, and related diabetes care consumables to IHS-operated medical centers nationwide. The company currently maintains two active blanket purchase agreements with the Indian Health Service, with this particular delivery order supporting diabetes supply procurement for Gallup Indian Medical Center beneficiaries. This award reflects Roche's competitive positioning on the GSA schedule and its role as a key vendor within the federal healthcare procurement ecosystem for diabetes diagnostic and management products.
Quick answers
Who was awarded contract 75H71025F80116?
75H71025F80116 was awarded to Roche Diabetes Care Inc. by Indian Health Service (Department of Health and Human Services) on March 24, 2025.
How much is contract 75H71025F80116 worth?
The government has obligated $244,000 on 75H71025F80116. Its potential value, with all options, is $550,000.
Is contract 75H71025F80116 an order under another contract?
Yes. 75H71025F80116 is a delivery order under V797D50597, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 75H71025F80116 competed?
The extent of competition for 75H71025F80116 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award